REMPLYA
Dead / Abandoned — Abandoned — no statement of use filed (as of 28 Jul 2025)
What this means for you
This application is over — abandoned 28 Jul 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98437140
- Mark type
- Stylized text
- Filed
- 06 Mar 2024
- Published for opposition
- 12 Nov 2024
- Abandoned
- 28 Jul 2025
- Attorney of record
- Gina A. Bibby
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy
- Class 042 — Scientific and technological services: Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines
- Class 044 — Medical, beauty and agricultural services: Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Owner
- Fulcrum Therapeutics, Inc., Cambridge, MA, US
- Fulcrum Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 28 Jul 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 28 Jul 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Nov 2024 — PUBLISHED FOR OPPOSITION
- 23 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Sept 2024 — ASSIGNED TO EXAMINER
- 19 Jul 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Mar 2024 — NEW APPLICATION ENTERED